MannKind Corp
MNKD
$4.18
Share price
2.45%
Change (1 day)
-3.24%
Change (1 year)
Categories
MannKind Corp (MNKD) - Cash on Hand
Cash on Hand as of December 2023 : $0.29 B
According to MannKind Corp's latest financial reports the company has $0.29 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
MannKind Corp - Cash on Hand chart (from 2004 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.29 B | 72.73% |
| 2022-12-31 | $0.17 B | -16.3% |
| 2021-12-31 | $0.20 B | 204.63% |
| 2020-12-31 | $67 M | 34.32% |
| 2019-12-31 | $49.88 M | -29.9% |
| 2018-12-31 | $71.15 M | 61.92% |
| 2017-12-31 | $43.94 M | 91.95% |
| 2016-12-31 | $22.89 M | -61.24% |
| 2015-12-31 | $59.07 M | -51.11% |
| 2014-12-31 | $0.12 B | 70.7% |
| 2013-12-31 | $70.79 M | 14.47% |
| 2012-12-31 | $61.84 M | 2206.6% |
| 2011-12-31 | $2.68 M | -96.19% |
| 2010-12-31 | $70.43 M | 116.75% |
| 2009-12-31 | $32.49 M | -30.11% |
| 2008-12-31 | $46.49 M | -87.38% |
| 2007-12-31 | $0.36 B | -15.62% |
| 2006-12-31 | $0.43 B | 199.71% |
| 2005-12-31 | $0.14 B | 60.86% |
| 2004-12-31 | $90.53 M | 61.83% |
| 2003-12-31 | $55.94 M | 80.17% |
| 2002-12-31 | $31.05 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $12.69 B | 4,200.25% | 🇺🇸 USA |
 Novo Nordisk NVO | $4.47 B | 1,417.17% | 🇩🇰 Denmark |
 Eli Lilly LLY | $2.92 B | 892.11% | 🇺🇸 USA |
 Merck MRK | $7.09 B | 2,303.60% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | $0.33 B | 13.86% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | $0.30 B | 2.89% | 🇺🇸 USA |